Terms: = Uterine cancer AND ER, estrogen receptor AND Treatment
795 results:
1. Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response.
Hu Z; Wu Z; Liu W; Ning Y; Liu J; Ding W; Fan J; Cai S; Li Q; Li W; Yang X; Dou Y; Wang W; Peng W; Lu F; Zhuang X; Qin T; Kang X; Feng C; Xu Z; Lv Q; Wang Q; Wang C; Wang X; Wang Z; Wang J; Jiang J; Wang B; Mills GB; Ma D; Gao Q; Li K; Chen G; Chen X; Sun C
Nat Genet; 2024 Apr; 56(4):637-651. PubMed ID: 38565644
[TBL] [Abstract] [Full Text] [Related]
2. Norcantharidin inhibits the malignant progression of cervical cancer by inducing endoplasmic reticulum stress.
Zhang Z; Sun B; Lu J; Bai P; Su Y; Li Y
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38456480
[TBL] [Abstract] [Full Text] [Related]
3. Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
Wang C; Zhang M; Peng J; Zhang M; Lu C; Qi X; Luo Q; Wang Y; Li G
Phytomedicine; 2024 Jun; 128():155504. PubMed ID: 38452404
[TBL] [Abstract] [Full Text] [Related]
4. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
[TBL] [Abstract] [Full Text] [Related]
5. PAX2 is regulated by estrogen/progesterone through promoter methylation in endometrioid adenocarcinoma and has an important role in carcinogenesis via the AKT/mTOR signaling pathway.
Chen H; Li L; Liu H; Qin P; Chen R; Liu S; Xiong H; Li Y; Yang Z; Xie M; Yang H; Jiang Q
J Pathol; 2024 Apr; 262(4):467-479. PubMed ID: 38185904
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
7. Hot-Spot Residue-Based Virtual Screening of Novel Selective estrogen-receptor Degraders for Breast cancer treatment.
Dai R; Bao X; Zhang Y; Huang Y; Zhu H; Yang K; Wang B; Wen H; Li W; Liu J
J Chem Inf Model; 2023 Dec; 63(23):7588-7602. PubMed ID: 37994801
[TBL] [Abstract] [Full Text] [Related]
8. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
[TBL] [Abstract] [Full Text] [Related]
9. estrogen receptor-related receptor γ uppresses hypoxia-induced angiogenesis by regulating VEGFA in endometrial cancer.
Wang XX; Hua T; Wang HB
Gynecol Endocrinol; 2023 Dec; 39(1):2264411. PubMed ID: 37859604
[TBL] [Abstract] [Full Text] [Related]
10. Research progress on the GRP78 gene in the diagnosis, treatment and immunity of cervical cancer.
Bai Y; Wang W; Cheng Y; Yang Y
Eur J Med Res; 2023 Oct; 28(1):447. PubMed ID: 37858217
[TBL] [Abstract] [Full Text] [Related]
11. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
[No Abstract] [Full Text] [Related]
12. uterine fibroid cell cytoskeletal organization is affected by altered G protein-coupled estrogen receptor-1 and phosphatidylinositol 3-kinase signaling.
Warwar R; Zupan AM; Nietupski C; Manzanares M; Hurley EG; Schutte SC
F S Sci; 2023 Nov; 4(4):327-338. PubMed ID: 37797815
[TBL] [Abstract] [Full Text] [Related]
13. Oxidative stress mediates the inhibitory effects of Manzamine A on uterine leiomyoma cell proliferation and extracellular matrix deposition via SOAT inhibition.
Lin LC; Chang HY; Kuo TT; Chen HY; Liu WS; Lo YJ; Hsia SM; Huang TC
Redox Biol; 2023 Oct; 66():102861. PubMed ID: 37666118
[TBL] [Abstract] [Full Text] [Related]
14. Ameliorative effects of a Chinese herbal formula, fufang meidengmu on uterine leiomyoma in a mice model.
Liping Yang -; Guangyun Zhang -; Deqiang Feng -; Maomao Zhang -; Xiaohua Duan -
Pak J Pharm Sci; 2023 May; 36(3):863-871. PubMed ID: 37580936
[TBL] [Abstract] [Full Text] [Related]
15. Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy.
Nordenskjöld A; Fohlin H; Rosell J; Bengtsson NO; Fornander T; Hatschek T; Lindman H; Malmström P; Rydén L; Wallgren A; Stål O; Nordenskjöld B
Breast; 2023 Oct; 71():63-68. PubMed ID: 37517154
[TBL] [Abstract] [Full Text] [Related]
16. Medroxyprogesterone as the Initial Systemic treatment of Recurrent Endometrial cancer: A Single Institutional Study.
Korosue M; Nakagawa K; Yoshiyasu K; Narita S; Isono-Taniguchi R; Takimoto Y; Ueda T; Omote M; Wakimoto YU; Tsubamoto H; Hirota S; Shibahara H
Anticancer Res; 2023 Aug; 43(8):3693-3699. PubMed ID: 37500122
[TBL] [Abstract] [Full Text] [Related]
17. The Application of 18 F-FES PET in Clinical cancer Care : A Systematic Review.
Huang YT; Chen TW; Chen LY; Huang YY; Lu YS
Clin Nucl Med; 2023 Sep; 48(9):785-795. PubMed ID: 37482660
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis.
Simon JA; Ferenczy A; Black D; Castonguay A; Royer C; Marouf R; Beauchemin C
Menopause; 2023 Aug; 30(8):855-866. PubMed ID: 37369079
[TBL] [Abstract] [Full Text] [Related]
19. Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in estrogen receptor Alpha-Mutant Endometrial cancer.
Blanchard Z; Rush CM; Arnesen S; Vahrenkamp JM; Rodriguez AC; Jarboe EA; Brown C; Chang MEK; Flory MR; Mohammed H; Modzelewska K; Lum DH; Gertz J
Mol Cancer Res; 2023 Oct; 21(10):1023-1036. PubMed ID: 37363949
[TBL] [Abstract] [Full Text] [Related]
20. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
Nigon E; Lefeuvre-Plesse C; Martinez A; Chauleur C; Lortholary A; Favier L; Bats AS; Guille A; AdélaÏde J; Finetti P; de Casteljac V; Provansal M; Mamessier E; Bertucci F; Ray-Coquard I; Sabatier R
J Transl Med; 2023 Jun; 21(1):408. PubMed ID: 37353806
[TBL] [Abstract] [Full Text] [Related]
[Next]
